Cook Pharmica’s award-winning mammalian cell culture manufacturing facility features a wide variety of prevalidated equipment to fulfill the drug substance project needs of clients. A team of scientists with a high degree of experience in cell culture and drug substance processing, whose mission is to consistently deliver a high-quality bulk drug substance under Current Good Manufacturing Practices (CGMP) guidelines, drives the state-of-the-art facility. The cell culture manufacturing operation is flexible because Cook Pharmica employs modular equipment and is able to handle a variety of biologics. With bioreactor capacity of up to 2,500 L, the facility is scalable for the majority of biologics. While it is general practice to be transparent with clients, Cook Pharmica exceeds expectations by extending transparency to the production areas, where clients have easy and clear access to view the operation.
|Facility Square Footage||124,000|
|Product Types||Monoclonal antibodies, recombinant proteins|
|Expression System||Mammalian cell culture|
|Key Services||CGMP cell banking, cell culture production, recovery and purification, bulk drug formulation|
|Production Scales||Commercial and clinical|